NCT02862015

Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients

A Multicenter, Prospective, Randomized Clinical Trial of the Clinical Effectiveness of Oncothermia Combined With Standard Chemotherapy in Metastatic Pancreatic Cancer Patients

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Patients with pancreatic cancer often suffer from pain. Because of such a pain, their quality of life have seriously deteriorated. There have been a few studies that showed an effect for pain control by hyperthermia (heating the patient's body). However, there are several limitations in conventional hyperthermia. In a previous pilot study (NCT02150135), we found the improvement of quality of life, function, and symptom. From this background, the investigators tried to show the effect of "Oncothermia" with conventional chemotherapy for pain control, increasing quality of life, and anti-tumor treatment.

Conditions

• Cancer, Pancreas

Interventions

Type	Name	Description
OTHER	Oncothermia	Oncothermia is a kind of hyperthermia treatment. It serves heat energy more selectively than conventional hyperthermia.
DRUG	FOLFIRINOX or Gemcitabine based chemotherapy	As a standard palliative chemotherapy, FOLFIRINOX or Gemcitabine based chemotherapy will be treated to the patients.

Timeline

• Start date: 2016-08-01
• Primary completion: 2019-07-01
• Completion: 2019-07-01
• First posted: 2016-08-10
• Last updated: 2017-10-31

Locations

1 site across 1 country: South Korea